2023-03-26 11:35:47
Latest Post
Zydus Lifesciences Ltd gets 3 observations from USFDA for Pharmex, Ahmedabad facility
Lupin announces Successful Completion of UK MHRA Inspection of its Pithampur Facilities
Kalyan Jewellers' brand ambassador Rashmika Mandanna inaugurates showroom at Vaishali Nagar, Jaipur
Motisons Jewellers files DRHP for IPO
PM inaugurates the RuPay National Common Mobility Card for Bangalore Metro with RBL Bank as Issuing Bank
Stock Report
Gujarat Terce Laboratories Ltd Q3 FY2023 loss at Rs. 0.28 lakhs
Posted On : 2023-01-31 22:18:43( TIMEZONE : IST )
GUJARAT TERCE LABORATORIES LTD. has reported Standalone financial results for the period ended December 31, 2022.
Financial Results (Q3 FY2023) - QoQ Comparison
The company has reported total income of Rs. 11.9891 crores during the period ended December 31, 2022 as compared to Rs. 12.6775 crores during the period ended September 30, 2022.
The company has posted net profit / (loss) of Rs. -0.0028 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs. -0.5889 crores for the period ended September 30, 2022.
The company has reported EPS of Rs. -0.0037 for the period ended December 31, 2022 as compared to Rs. -0.79 for the period ended September 30, 2022.
| Financials | Q3 FY2023 | Q2 FY2023 | % Change |
| Total Income | ₹11.9891 crs | ₹12.6775 crs |  -5.43% |
| Net Profit | ₹-0.0028 crs | ₹-0.5889 crs |  99.52% |
| EPS | ₹-0.0037 | ₹-0.79 | 99.53% |
Financial Results (Q3 FY2023) - YoY Comparison
The company has reported total income of Rs.11.9891 crores during the period ended December 31, 2022 as compared to Rs.10.8157 crores during the period ended December 31, 2021.
The company has posted net profit / (loss) of Rs.-0.0028 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs.0.4771 crores for the period ended December 31, 2021.
The company has reported EPS of Rs.-0.0037 for the period ended December 31, 2022 as compared to Rs.0.64 for the period ended December 31, 2021.
| Financials | Q3 FY2023 | Q3 FY2022 | % Change |
| Total Income | ₹11.9891 crs | ₹10.8157 crs |  10.85% |
| Net Profit | ₹-0.0028 crs | ₹0.4771 crs | -100.59% |
| EPS | ₹-0.0037 | ₹0.64 | -100.58% |
Financial Results (9 Months Ended FY2023) - YoY Comparison
The company has reported total income of Rs.34.1471 crores during the 9 Months period ended December 31, 2022 as compared to Rs.31.0226 crores during the 9 Months period ended December 31, 2021.
The company has posted net profit / (loss) of Rs.-2.4750 crores for the 9 Months period ended December 31, 2022 as against net profit / (loss) of Rs.2.5311 crores for the 9 Months period ended December 31, 2021.
The company has reported EPS of Rs.-3.34 for the 9 Months period ended December 31, 2022 as compared to Rs.3.41 for the 9 Months period ended December 31, 2021.
| Financials | 9 Months Ended FY2023 | 9 Months Ended FY2022 | % Change |
| Total Income | ₹34.1471 crs | ₹31.0226 crs | 10.07% |
| Net Profit | ₹-2.4750 crs | ₹2.5311 crs | -197.78% |
| EPS | ₹-3.34 | ₹3.41 | -197.95% |
Shares of GUJARAT TERCE LABORATORIES LTD. was last trading in BSE at Rs. 19.20 as compared to the previous close of Rs. 18.30. The total number of shares traded during the day was 4664 in over 37 trades.
The stock hit an intraday high of Rs. 19.20 and intraday low of 18.00. The net turnover during the day was Rs. 86314.00.
